Federal award
MEDPHARM INC.
N6809621P0053
Contract
Obligated and Ceiling
- Obligated (net)
- $163,850.56
- Ceiling (potential value, not spending)
- $163,850.56
- Current value
- $163,850.56
- Gross positive obligations
- $163,850.56
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MEDPHARM INC. · DLM6VHZ3VUN3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MEDPHARM INC. · DLM6VHZ3VUN3
- Awarding agency
- Department of War · sub-agency 1700 · office N68096
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6809621P0053
- Award type code
- B
- Actions
- 3 · Sep 29, 2021 to Sep 20, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 20, 2022 | FY2022 | P00002 | B | $0.00 | — |
| Oct 13, 2021 | FY2022 | P00001 | C | $163,850.56 | — |
| Sep 29, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.